REGN vs. MRK
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or MRK.
Correlation
The correlation between REGN and MRK is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. MRK - Performance Comparison
Key characteristics
REGN:
-1.17
MRK:
-1.38
REGN:
-1.60
MRK:
-1.86
REGN:
0.80
MRK:
0.75
REGN:
-0.61
MRK:
-0.86
REGN:
-1.12
MRK:
-1.65
REGN:
29.62%
MRK:
21.30%
REGN:
28.44%
MRK:
25.66%
REGN:
-91.81%
MRK:
-68.62%
REGN:
-50.03%
MRK:
-38.54%
Fundamentals
REGN:
$64.01B
MRK:
$198.72B
REGN:
$38.50
MRK:
$6.74
REGN:
15.27
MRK:
11.68
REGN:
0.94
MRK:
0.72
REGN:
4.51
MRK:
3.10
REGN:
2.19
MRK:
4.28
REGN:
$11.06B
MRK:
$48.39B
REGN:
$9.40B
MRK:
$39.64B
REGN:
$3.94B
MRK:
$19.98B
Returns By Period
In the year-to-date period, REGN achieves a -15.69% return, which is significantly higher than MRK's -19.05% return. Over the past 10 years, REGN has underperformed MRK with an annualized return of 2.41%, while MRK has yielded a comparatively higher 7.14% annualized return.
REGN
-15.69%
-5.42%
-35.35%
-33.76%
1.19%
2.41%
MRK
-19.05%
-9.14%
-23.33%
-35.27%
3.69%
7.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. MRK — Risk-Adjusted Performance Rank
REGN
MRK
REGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. MRK - Dividend Comparison
REGN's dividend yield for the trailing twelve months is around 0.15%, less than MRK's 3.96% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.96% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
REGN vs. MRK - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for REGN and MRK. For additional features, visit the drawdowns tool.
Volatility
REGN vs. MRK - Volatility Comparison
Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.61% compared to Merck & Co., Inc. (MRK) at 10.96%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities